ARCHIVES

In Brief: Wittes To Become Acting DCT Director; Kaufman Leaves NCI For Private Practice

This article is from The Cancer Letter archive.

Vol. 21 No. 07 | February 17, 1995

Download PDF Visit The Full Archive

Related Articles

Haller Named Editor-In-Chief Of JCO; White House Appoints Duffy To NCAB.

March 17, 2000

FDA Approves Abbott’s HER-2 DNA Probe Kit.

January 25, 2002

Arizona Cancer Center Convinces State To Set Lower Limits For Aflatoxin

February 23, 1979

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006

NCI Seeks Prevention Fellows.

March 9, 2001

Bristol-Myers Adds UCLA, Fox Chase To Grants Program

April 12, 1985